Assured Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Assured Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,689	Closed	-$341K	–	597
2016 Q3	$341K	Buy	+3,689	New	+$347K	0.01%	465
2015 Q3	–	Sell	-459	Closed	-$63K	–	612
2015 Q2	$63K	Buy	+459	New	+$56.9K	﹤0.01%	592
2015 Q1	–	Sell	-36,000	Closed	-$3.25M	–	574
2014 Q4	$3.25M	Sell	36,000 -24,800	-41%	-$2.06M	0.06%	174
2014 Q3	$4.39M	Sell	60,800 -6,600	-10%	-$434K	0.07%	156
2014 Q2	$4.19M	Buy	+67,400	New	+$4.07M	0.07%	153

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Assured Investment Management's BMRN Position: Q4 2016 in Review

Assured Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2016, closing a stake of 3,689 shares — an estimated $341K sold.

Assured Investment Management first reported a position in BMRN in Q2 2014 and held it in 5 quarters. The position peaked at $4.39M in Q3 2014. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

Assured Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Assured Investment Management sold 3,689 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $341K.
Assured Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2014 and held it in 5 quarters.
Assured Investment Management's BioMarin Pharmaceuticals position peaked at $4.39M in Q3 2014.
415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on Assured Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.